scholarly journals Pathology of Fatal West Nile Virus Infections in Native and Exotic Birds during the 1999 Outbreak in New York City, New York

2000 ◽  
Vol 37 (3) ◽  
pp. 208-224 ◽  
Author(s):  
K. E. Steele ◽  
M. J. Linn ◽  
R. J. Schoepp ◽  
N. Komar ◽  
T. W. Geisbert ◽  
...  

West Nile fever caused fatal disease in humans, horses, and birds in the northeastern United States during 1999. We studied birds from two wildlife facilities in New York City, New York, that died or were euthanatized and were suspected to have West Nile virus infections. Using standard histologic and ultrastructural methods, virus isolation, immunohistochemistry, in situ hybridization and reverse-transcriptase polymerase chain reaction, we identified West Nile virus as the cause of clinical disease, severe pathologic changes, and death in 27 birds representing eight orders and 14 species. Virus was detected in 23/26 brains (88%), 24/25 hearts (96%), 15/18 spleens (83%), 14/20 livers (70%), 20/20 kidneys (100%), 10/13 adrenals (77%), 13/14 intestines (93%), 10/12 pancreata (83%), 5/12 lungs (42%), and 4/8 ovaries (50%) by one or more methods. Cellular targets included neurons and glial cells in the brain, spinal cord, and peripheral ganglia; myocardial fibers; macrophages and blood monocytes; renal tubular epithelium; adrenal cortical cells; pancreatic acinar cells and islet cells; intestinal crypt epithelium; oocytes; and fibroblasts and smooth muscle cells. Purkinje cells were especially targeted, except in crows and magpies. Gross hemorrhage of the brain, splenomegaly, menin-goencephalitis, and myocarditis were the most prominent lesions. Immunohistochemistry was an efficient and reliable method for identifying infected cases, but the polyclonal antibody cross-reacted with St. Louis encephalitis virus and other flaviviruses. In contrast, the in situ hybridization probe pWNV-E (WN-USAMRIID99) reacted only with West Nile virus. These methods should aid diagnosticians faced with the emergence of West Nile virus in the United States.

2004 ◽  
Vol 112 (11) ◽  
pp. 1183-1187 ◽  
Author(s):  
Adam M. Karpati ◽  
Mary C. Perrin ◽  
Tom Matte ◽  
Jessica Leighton ◽  
Joel Schwartz ◽  
...  

Transfusion ◽  
2012 ◽  
Vol 52 (12) ◽  
pp. 2664-2670 ◽  
Author(s):  
Richard O. Francis ◽  
Donna Strauss ◽  
Joan Dunn Williams ◽  
Shavonne Whaley ◽  
Beth H. Shaz

2002 ◽  
Vol 67 (1) ◽  
pp. 67-75 ◽  
Author(s):  
George V Ludwig ◽  
Julie A Hile ◽  
Joseph A Mangiafico ◽  
Tracy L Clippinger ◽  
Bonnie L Raphael ◽  
...  

Author(s):  
John M. Drake ◽  
Krisztian Magori ◽  
Kevin Knoblich ◽  
Sarah E. Bowden ◽  
Waheed I. Bajwa

The size of annual outbreaks in seasonally forced host-pathogen systems is poorly understood. We studied contributing factors to the six-fold observed variation in the number of human cases of West Nile virus in New York City in the years 2000–2008. Sampling error and intrinsic noise (demographic stochasticity) explain roughly half of the observed variation. To investigate the remaining sources of variation, we estimated the monthly force of infection from data on the distribution and abundance of mosquitoes, virus prevalence, vector competence, and mammal biting rate at two spatial scales. At both scales, the West Nile virus force of infection was remarkably consistent from year to year. We propose that fine scale spatial heterogeneity is the key to understanding the epidemiology of West Nile virus in New York City.


2018 ◽  
Vol 2018 ◽  
pp. 1-4 ◽  
Author(s):  
Yahya Salim Yahya Al-Fifi ◽  
Kamran Kadkhoda ◽  
Mike Drebot ◽  
Beverly Wudel ◽  
E. J. Bow

The 1999 New York City outbreak of West Nile virus (WNV) was associated with a high incidence of West Nile virus neuroinvasive disease (WNVND) where the outcomes for these patients were very poor. We describe a case of West Nile virus neuroinvasive disease (WNVND) characterized by acute flaccid quadriplegia with a favorable outcome in Winnipeg, Manitoba, Canada.


2002 ◽  
Vol 76 (12) ◽  
pp. 5847-5856 ◽  
Author(s):  
Pei-Yong Shi ◽  
Mark Tilgner ◽  
Michael K. Lo ◽  
Kim A. Kent ◽  
Kristen A. Bernard

ABSTRACT We report the first full-length infectious clone of the current epidemic, lineage I, strain of West Nile virus (WNV). The full-length cDNA was constructed from reverse transcription-PCR products of viral RNA from an isolate collected during the year 2000 outbreak in New York City. It was cloned into plasmid pBR322 under the control of a T7 promoter and stably amplified in Escherichia coli HB101. RNA transcribed from the full-length cDNA clone was highly infectious upon transfection into BHK-21 cells, resulting in progeny virus with titers of 1 × 109 to 5 × 109 PFU/ml. The cDNA clone was engineered to contain three silent nucleotide changes to create a StyI site (C to A and A to G at nucleotides [nt] 8859 and 8862, respectively) and to knock out an EcoRI site (A to G at nt 8880). These genetic markers were retained in the recovered progeny virus. Deletion of the 3′-terminal 199 nt of the cDNA transcript abolished the infectivity of the RNA. The plaque morphology, in vitro growth characteristics in mammalian and insect cells, and virulence in adult mice were indistinguishable for the parental and recombinant viruses. The stable infectious cDNA clone of the epidemic lineage I strain will provide a valuable experimental system to study the pathogenesis and replication of WNV.


2001 ◽  
Vol 7 (4) ◽  
pp. 736-738 ◽  
Author(s):  
Nicholas Komar ◽  
Nicholas A. Panella ◽  
Edward Boyce

Sign in / Sign up

Export Citation Format

Share Document